Literature DB >> 16365753

Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer.

E Vairaktaris1, C Yapijakis, P Kessler, A Vylliotis, J Ries, J Wiltfang, S Vassiliou, S Derka, F W Neukam.   

Abstract

PURPOSE: We investigated whether the mutant methylenetetrahydrofolate reductase (MTHFR) increases risk for oral cancer. The common germ-line mutation C677T in the MTHFR gene significantly diminishes specific activity of the enzyme, which is responsible for the circulating form of folate. Folate deficiency is associated with increased risk for thrombosis, as well as for several types of cancer, through disruption of DNA methylation, DNA synthesis and deficient DNA repair.
METHODS: We searched for the C677T mutation by restriction fragment analysis of PCR products in DNA samples of 110 patients with oral squamous cell carcinoma and 120 healthy controls of comparable ethnicity, age and sex.
RESULTS: The number of heterozygotes was significantly different in the two groups (P<0.005), as well as in subgroups of patients with or without a positive family history for cancer, compared to normal controls (P<0.01 and P<0.005, respectively). Furthermore, the subgroup of patients with a positive family history for thrombophilia had a significant increase both in the frequencies of mutant alleles (P<0.01) and heterozygotes (P<0.001) in comparison to normal controls.
CONCLUSIONS: The obtained results suggest that the MTHFR mutation is a minor contributing factor in oncogenesis in the oral region, in conjunction with low dietary uptake of folate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365753     DOI: 10.1007/s00432-005-0065-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

1.  Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations.

Authors:  P A Isotalo; G A Wells; J G Donnelly
Journal:  Am J Hum Genet       Date:  2000-08-24       Impact factor: 11.025

Review 2.  Folate and carcinogenesis: an integrated scheme.

Authors:  S W Choi; J B Mason
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

3.  Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos.

Authors:  Henrik Zetterberg; Björn Regland; Mona Palmér; Anne Ricksten; Lars Palmqvist; Lars Rymo; Demetrios A Arvanitis; Demetrios A Spandidos; Kaj Blennow
Journal:  Eur J Hum Genet       Date:  2002-02       Impact factor: 4.246

4.  Micronutrients and the risk of colorectal adenomas.

Authors:  M Tseng; S C Murray; L L Kupper; R S Sandler
Journal:  Am J Epidemiol       Date:  1996-12-01       Impact factor: 4.897

5.  Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China.

Authors:  Rachael Z Stolzenberg-Solomon; You-Lin Qiao; Christian C Abnet; D Luke Ratnasinghe; Sanford M Dawsey; Zhi Wei Dong; Philip R Taylor; Steven D Mark
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

Review 6.  Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.

Authors:  Robert J Kim; Richard C Becker
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

7.  Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.

Authors:  Kyoung-Jin Sohn; Ruth Croxford; Zoe Yates; Mark Lucock; Young-In Kim
Journal:  J Natl Cancer Inst       Date:  2004-01-21       Impact factor: 13.506

8.  Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer.

Authors:  K Jaskiewicz; W F Marasas; C Lazarus; A D Beyers; P D Van Helden
Journal:  Anticancer Res       Date:  1988 Jul-Aug       Impact factor: 2.480

9.  Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.

Authors:  Maja Krajinovic; Stephanie Lamothe; Damian Labuda; Emilie Lemieux-Blanchard; Yves Theoret; Albert Moghrabi; Daniel Sinnett
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

10.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

Authors:  P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

View more
  19 in total

1.  Retrospective case-control study of correlation between MTHFR gene and OSCC risk in North India.

Authors:  Hena Naqvi; Mohammad Kaleem Ahmad; Syed Rizwan Hussain; Shalini Gupta; Mohammad Waseem; Abbas Ali Mahdi
Journal:  Clin Oral Investig       Date:  2016-10-24       Impact factor: 3.573

2.  Positive association between MTHFR C677T polymorphism and oral cancer risk: a meta-analysis.

Authors:  Juan Jia; Zheng Ma; Shuangjiang Wu
Journal:  Tumour Biol       Date:  2014-02-01

3.  Late causes of death in children treated for CNS malignancies.

Authors:  Stephanie M Perkins; Wan Fei; Nandita Mitra; Eric T Shinohara
Journal:  J Neurooncol       Date:  2013-07-05       Impact factor: 4.130

4.  Polymorphisms and haplotypes in methylenetetrahydrofolate reductase gene and head and neck squamous cell carcinoma risk.

Authors:  Ana Lívia Silva Galbiatti; Mariangela Torreglosa Ruiz; Juliana Olsen Rodrigues; Luiz Sérgio Raposo; José Victor Maníglia; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

5.  Evidence of high mortality in long term survivors of childhood medulloblastoma.

Authors:  Matthew S Ning; Stephanie M Perkins; Todd Dewees; Eric T Shinohara
Journal:  J Neurooncol       Date:  2015-01-04       Impact factor: 4.130

6.  Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer.

Authors:  Christos Yapijakis; Michael Kechagiadakis; Emeka Nkenke; Zoe Serefoglou; Dimitrios Avgoustidis; Antonis Vylliotis; Despina Perrea; Friedrich W Neukam; Efstratios Patsouris; Eleftherios Vairaktaris
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

7.  Analysis of primary risk factors for oral cancer from select US states with increasing rates.

Authors:  Anthony Bunnell; Nathan Pettit; Nicole Reddout; Kanika Sharma; Susan O'Malley; Michelle Chino; Karl Kingsley
Journal:  Tob Induc Dis       Date:  2010-02-23       Impact factor: 2.600

Review 8.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

9.  The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies.

Authors:  Min Tang; Shang-Qian Wang; Bian-Jiang Liu; Qiang Cao; Bing-Jie Li; Peng-Chao Li; Yong-Fei Li; Chao Qin; Wei Zhang
Journal:  Mol Biol Rep       Date:  2014-04-18       Impact factor: 2.316

10.  The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer.

Authors:  C Yapijakis; E Vairaktaris; S Vassiliou; A Vylliotis; E Nkenke; A M Nixon; S Derka; S Spyridonidou; E Vorris; F Neukam; E Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-13       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.